Standing Together Against Policy Changes: Advocacy Resources for Remedy GPO Members

Biosimilar Adoption in 2026: What Every Specialty Practice Needs to Know

Optimizing Infusion Center Capacity in 2026: Strategies to Do More Without Expanding Footprint

Faster Rituximab Infusions in Rheumatology: Evidence Supports Safe, Efficient Care Delivery

The Hidden Financial Risk of Biologic Therapy Volatility in Neurology

2026 PBM Formulary Exclusions: What Independent Practices Need to Know About Biosimilars, Net Pricing, and Market Access

Harnessing Patient Experience Data to Improve Infusion Practice Performance

The Next Front in Drug Pricing: What Medicare Drug Negotiation Means for Buy-and-Bill Infusion Practices

Reducing Infusion No-Shows and Late Cancellations: Practical Strategies for Specialty Practices to Protect Capacity and Revenue